Dr. Michael G. Desautel, MD

Dr. Desautel practices at Advanced Urology Institute in Oxford, Florida.

Dr. Desautel's NPI, 1831161660, was assigned on February 6, 2006. Dr. Desautel graduated from Icahn School Of Medicine At Mount Sinai in 1992. Dr. Desautel holds Florida license ME78107.

Dr. Desautel's primary practice is Advanced Urology Institute, at 12109 County Rd 103, Oxford, FL 34484 in Sumter County. The practice phone is (352) 391-6494.

Dr. Desautel's primary practice is Advanced Urology Institute in Oxford, Florida. Dr. Desautel is also affiliated with HCA Florida Citrus Hospital. The medical group on file is Advanced Urology Institute. Dmand AI also links Dr. Desautel to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desautel practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Desautel's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Desautel is board certified in urology by the American Board of Urology. Dmand AI has Dr. Desautel's licenses on file in 2 states: Florida and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Desautel treats.

CMS data shows 7,273 Medicare services from Dr. Desautel across 32 procedure codes in 2024, for 1,106 Medicare patients. Medicare paid $231,893 for them.

CMS counts 1,106 Medicare patients who saw Dr. Desautel in 2024. The largest group is 75 to 84, with 516 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Desautel's median patient age at 75, with 22% women.

In 2024, Dr. Desautel wrote 2,447 Medicare Part D claims for 761 patients. 95% of them were for generic drugs. CMS names the drug for 2,328 of them, across 21 drugs with 11 or more claims each, at $161,192 in total drug cost. In 2023, CMS named 2,104 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Desautel for performance year 2024, reported as part of a group. Dr. Desautel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Desautel. The most frequent topics are Urinary Incontinence, Stress, Electrosurgery and Prostatic Hyperplasia. Dr. Desautel has published most often in Neurourol Urodyn. Dr. Desautel's most frequent co-authors are Gopal H. Badlani, MD, Hilary Alan Brodie, MD and Tracy L. Burney, MD.

CMS Open Payments shows 159 general payments to Dr. Desautel from 29 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 79% of the total. Innovative Medical Technologies, LLC paid the most, $21,250.

Dr. Desautel graduated from Icahn School Of Medicine At Mount Sinai in 1992.

Dr. Desautel is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.